External Infusion Pumps
National · Effective Jan 25, 2026
1 active Medicare policy lists J3285, and 16 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Jan 25, 2026
16 policies from 7 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J3285 |
|---|---|---|
| Treprostinil (Remodulin)Effective 04/01/2022 - 03/31/2023 | Apr 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Treprostinil (Remodulin)Effective 04/01/2023 - 02/29/2024 | Apr 1, 2023 | Prior auth requiredInferred from policy title |
| Treprostinil (Remodulin)Effective 05/01/2021 - 03/31/2022 | May 1, 2021 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Treprostinil (Remodulin)Effective 06/01/2020 - 04/30/2021 | Jun 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Treprostinil (Remodulin)Effective 07/01/2019 - 05/31/2020 | Jul 1, 2019 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Treprostinil Injection (Remodulin, generic) | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Treprostinil Injection (Remodulin, generic)Effective 03/01/2025 - 02/28/2026 | Mar 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Treprostinil injection (Remodulin)Effective 01/01/2019 - 06/30/2019 | Jan 1, 2019 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Tresprostinil Products(Remodulin,generic treprostinil)Effective 03/01/2024 - 02/28/2025 | Mar 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J3285 |
|---|---|---|
| Iontophoresis | Apr 26, 2023 | Covered |
| Pulmonary Hypertension Treatments and Selected Indications of Prostanoids | Aug 30, 2023 | Covered |
| Policy | Effective | Status of J3285 |
|---|---|---|
| Treprostinil injection (Remodulin); Treprostinil | Jun 1, 2002 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3285 |
|---|---|---|
| Treprostinil (Orenitram, Remodulin, Tyvaso, Tyvaso DPI, Yutrepia); CP.PHAR.199 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3285 |
|---|---|---|
| Provider Administered Drugs – Preferred Products | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J3285 |
|---|---|---|
| Provider Administered Drugs – Preferred Products | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J3285 |
|---|---|---|
| Provider Administered Drugs – Preferred Products | Jul 1, 2026 | Covered |